Episode 22: Clinical Trials, Drug Development & The Future of Precision Medicine
Over the past decade, cancer treatment has gone from a one-size-fits-all approach to a targeted and personal approach known widely as Precision Medicine.\n\xa0 Among the leaders at TGen pushing the boundaries of this new frontier is Dr. Sunil Sharma, Deputy Director of TGen Clinical Sciences, Professor, and Division Director in the Applied Cancer Research and Drug Discovery division.\n\xa0 Dr. Sharma is a well-known cancer investigator, responsible for helping develop some of the world\u2019s most advanced anti-cancer agents.\xa0\n\xa0 In episode 22 of\xa0TGen Talks, Dr. Sharma discusses his work in drug development and patient clinical trials in concert with City of Hope in California, and TGen\u2019s clinical partnership with the HonorHealth Research Institute.\xa0Whether in the clinic, or at the bench, his work helps bring precision medicine solutions to patients\nin need.